Michelle Kuzma

609 total citations
19 papers, 509 citations indexed

About

Michelle Kuzma is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michelle Kuzma has authored 19 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michelle Kuzma's work include Chronic Myeloid Leukemia Treatments (3 papers), Adenosine and Purinergic Signaling (3 papers) and Bone Tissue Engineering Materials (2 papers). Michelle Kuzma is often cited by papers focused on Chronic Myeloid Leukemia Treatments (3 papers), Adenosine and Purinergic Signaling (3 papers) and Bone Tissue Engineering Materials (2 papers). Michelle Kuzma collaborates with scholars based in Canada, United States and China. Michelle Kuzma's co-authors include Vijaya L. Damaraju, Michael B. Sawyer, Jian Yang, Carol E. Cass, Xiaochun Bai, Cheng Dong, Delores Mowles, Carla M. Prado, Robert R. Bies and John R. Mackey and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Advanced Functional Materials.

In The Last Decade

Michelle Kuzma

19 papers receiving 504 citations

Peers

Michelle Kuzma
Wei‐Dong Lü China
Tessa M. Simone United States
Guillermo De Angulo United States
Anjali A. Roeth Germany
Lan Sun China
Bobe Petrushev Romania
Ying Hu China
Xiaochen Liu China
David A. Mahvi United States
Wei‐Dong Lü China
Michelle Kuzma
Citations per year, relative to Michelle Kuzma Michelle Kuzma (= 1×) peers Wei‐Dong Lü

Countries citing papers authored by Michelle Kuzma

Since Specialization
Citations

This map shows the geographic impact of Michelle Kuzma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Kuzma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Kuzma more than expected).

Fields of papers citing papers by Michelle Kuzma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Kuzma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Kuzma. The network helps show where Michelle Kuzma may publish in the future.

Co-authorship network of co-authors of Michelle Kuzma

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Kuzma. A scholar is included among the top collaborators of Michelle Kuzma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Kuzma. Michelle Kuzma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kuzma, Michelle, Xinyu Tan, Tong‐Chuan He, et al.. (2021). Phototherapy and optical waveguides for the treatment of infection. Advanced Drug Delivery Reviews. 179. 114036–114036. 47 indexed citations
2.
Guo, Jinshan, Xinggui Tian, Denghui Xie, et al.. (2020). Citrate‐Based Tannin‐Bridged Bone Composites for Lumbar Fusion. Advanced Functional Materials. 30(27). 74 indexed citations
3.
Damaraju, Vijaya L., Maral Aminpour, Michelle Kuzma, et al.. (2020). Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT‐1: Influence on 18F‐FDG PET Uptake. Clinical and Translational Science. 14(3). 847–858. 7 indexed citations
4.
Guo, Jinshan, Xinggui Tian, Denghui Xie, et al.. (2020). Bone Composites: Citrate‐Based Tannin‐Bridged Bone Composites for Lumbar Fusion (Adv. Funct. Mater. 27/2020). Advanced Functional Materials. 30(27). 4 indexed citations
5.
Ma, Chuying, Michelle Kuzma, Xiaochun Bai, & Jian Yang. (2019). Biomaterial‐Based Metabolic Regulation in Regenerative Engineering. Advanced Science. 6(19). 1900819–1900819. 51 indexed citations
6.
Damaraju, Vijaya L., Michelle Kuzma, Carol E. Cass, Charles T. Putman, & Michael B. Sawyer. (2018). Multitargeted kinase inhibitors imatinib, sorafenib and sunitinib perturb energy metabolism and cause cytotoxicity to cultured C2C12 skeletal muscle derived myotubes. Biochemical Pharmacology. 155. 162–171. 25 indexed citations
7.
Damaraju, Vijaya L., et al.. (2016). Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors. Journal of Biological Chemistry. 291(36). 18809–18817. 18 indexed citations
8.
Sawyer, Michael B., Edith Pituskin, Sambasivarao Damaraju, et al.. (2015). A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical Breast Cancer. 16(2). 139–144.e3. 17 indexed citations
9.
Chu, Michael P., Cynthia Stretch, Charles Butts, et al.. (2015). Development of a new equation to estimate creatinine clearance in cancer patients. Cancer Chemotherapy and Pharmacology. 76(1). 117–124. 3 indexed citations
10.
Damaraju, Vijaya L., Michelle Kuzma, Carol E. Cass, & Michael B. Sawyer. (2015). Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors. Cancer Chemotherapy and Pharmacology. 76(5). 1093–1098. 4 indexed citations
11.
Damaraju, Vijaya L., Michelle Kuzma, Delores Mowles, Carol E. Cass, & Michael B. Sawyer. (2014). Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?. Molecular Cancer Therapeutics. 14(1). 236–245. 21 indexed citations
12.
Damaraju, Vijaya L., Delores Mowles, Marnie Goodwin Wilson, et al.. (2013). Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers. Biochemistry and Cell Biology. 91(6). 419–427. 8 indexed citations
13.
Damaraju, Vijaya L., Delores Mowles, Michelle Kuzma, et al.. (2013). Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity. Clinical Cancer Research. 20(1). 176–186. 35 indexed citations
14.
Prado, Carla M., Isac Lima, Vickie E. Baracos, et al.. (2010). An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemotherapy and Pharmacology. 67(1). 93–101. 131 indexed citations
15.
Elwi, Adam, Vijaya L. Damaraju, Michelle Kuzma, et al.. (2009). Transepithelial fluxes of adenosine and 2′-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3. American Journal of Physiology-Renal Physiology. 296(6). F1439–F1451. 19 indexed citations
16.
Sawyer, Michael B., Edith Pituskin, Vijaya L. Damaraju, et al.. (2009). Uridine glucuronosyltransferase 2B7 pharmacogenetics predicts epirubicin clearance and myelosuppression. Journal of Clinical Oncology. 27(15_suppl). 2504–2504. 3 indexed citations
17.
Damaraju, Vijaya L., Delores Mowles, Michelle Kuzma, et al.. (2008). Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: Characterization of a novel nucleobase transport activity. Biochemical Pharmacology. 75(10). 1901–1911. 8 indexed citations
18.
Elwi, Adam, Vijaya L. Damaraju, Michelle Kuzma, et al.. (2008). Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures. Cancer Chemotherapy and Pharmacology. 63(2). 289–301. 12 indexed citations
19.
Schultes, Birgit C., et al.. (2001). Characterization of an Anti-MUC1 Monoclonal Antibody with Potential as a Cancer Vaccine. PubMed. 20(5-6). 313–324. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Dong Lü Breakdown of academic impact, for papers by Tessa M. Simone Breakdown of academic impact, for papers by Guillermo De Angulo Breakdown of academic impact, for papers by Anjali A. Roeth Breakdown of academic impact, for papers by Lan Sun Breakdown of academic impact, for papers by Bobe Petrushev Breakdown of academic impact, for papers by Ying Hu Breakdown of academic impact, for papers by Xiaochen Liu Breakdown of academic impact, for papers by David A. Mahvi
Rankless by CCL
2026